Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France-Reference-Cited by-同舟云学术

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

Published:2019-02-11 Issue:5 Volume:74 Page:1417-1424
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Assoumou Lambert¹,Bocket Laurence²,Pallier Coralie³,Grude Maxime¹,Ait-Namane Rachid¹,Izopet Jacques⁴,Raymond Stéphanie⁴^ORCID,Charpentier Charlotte⁵⁶,Visseaux Benoit⁵⁶,Wirden Marc¹⁷,Trabaud Mary-Anne⁸,Le Guillou-Guillemette Hélène⁹,Allaoui Chakib¹⁰,Henquell Cécile¹¹,Krivine Anne¹²,Dos Santos Georges¹³,Delamare Catherine¹⁴,Bouvier-Alias Magali¹⁵,Montes Brigitte¹⁶,Ferre Virginie¹⁷,De Monte Anne¹⁸,Signori-Schmuck Anne¹⁹,Maillard Anne²⁰,Morand-Joubert Laurence¹²¹²²,Tumiotto Camille²³,Fafi-Kremer Samira²⁴,Amiel Corinne²⁵,Barin Francis²⁶,Marque-Juillet Stéphanie²⁷,Courdavault Laurence²⁸,Vallet Sophie²⁹,Beby-Defaux Agnès³⁰,de Rougemont Alexis³¹,Fenaux Honorine³²,Avettand-Fenoel Véronique³³³⁴,Allardet-Servent Annick³⁵,Plantier Jean-Christophe³⁶,Peytavin Gilles⁶³⁷,Calvez Vincent¹⁷²²,Chaix Marie-Laure³⁸,Descamps Diane⁵⁶,

Affiliation:

1. INSERM, UMR 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France

2. CHU Lille, Virology, Lille, France

3. Hopital Paul Brousse HUPS, Villejuif, France

4. CHU Purpan, Toulouse, France

5. Hopital Bichat Claude Bernard, Virology, Paris, France

6. Univ Paris-Diderot, INSERM UMR 1137, CNR VIH, Paris, France

7. CHU Pitié-Salpêtrière, Virology, Paris, France

8. Hôpital de la Croix Rousse, Virology, Lyon, France

9. CHU Angers, Angers, France

10. Hopital Avicenne, Virology, Bobigny, France

11. CHU Clermont-Ferrand, Virology, Clermont-Ferrand, France

12. Hopital Cochin, Virology, Paris, France

13. CHU de Martinique, Virology, EA 3547, Fort de France, France

14. CHU Metz-Thionville, Virology, Metz, France

15. CHU Henri Mondor, Virology, Créteil, France

16. CHU Montpellier, Virology, Montpellier, France

17. CHU Nantes, Virology, Nantes, France

18. CHU Nice, Virology, Nice, France

19. CHU Grenoble Alpes, Virology, Grenoble, France

20. CHU Rennes, Virology, Rennes, France

21. Hopital Saint-Antoine, Virology, Paris, France

22. Sorbonne Université, Paris, France

23. CHU Bordeaux, Virology, Bordeaux, France

24. CHU Strasbourg, Virology, Strasbourg, France

25. Hopital Tenon, Virology, Paris, France

26. CHU Tours, Virology, Tours, France

27. CHU Versailles, Virology, Versailles, France

28. CH Argenteuil, Virology, Argenteuil, France

29. CHU Brest, Virology, Brest, France

30. CHU Poitiers, Virology, Poitiers, France

31. CHU Dijon, Virology, Dijon, France

32. CHU Nancy, Virology, Nancy, France

33. CHU Necker-Enfants Malades, Virology, Paris, France

34. Université Paris Descartes, Sorbonne Paris Cité, Paris, France

35. CHU-Nimes, Virology, Nimes, France

36. Normandie Univ, UNIROUENRouen, EA2656, Rouen University Hospital, Virology, Rouen, France

37. Hopital Bichat-Claude Bernard, Laboratoire de Pharmaco-Toxicologie, Paris, France

38. Hopital Saint-Louis, Virology, INSERM U944, CNR VIH, Paris, France

Funder

VIH

SIDA

ANRS

France REcherche Nord&Sud Sida-hiv Hépatites

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/5/1417/28501317/dkz011.pdf

Reference23 articles.

1. Antiretroviral therapy for the prevention of HIV-1 transmission;Cohen;N Engl J Med,2016

2. Initiation of antiretroviral therapy in early asymptomatic HIV infection;Group;N Engl J Med,2015

3. A trial of early antiretrovirals and isoniazid preventive therapy in Africa;Group;N Engl J Med,2015

4. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study;Wittkop;Lancet Infect Dis,2011

5. Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society-USA panel;Gunthard;Clin Infect Dis,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21;Journal of Antimicrobial Chemotherapy;2024-07-19

2. Optimization of HIV Sequencing Method Using Vela Sentosa Library on Miseq Ilumina Platform;Genes;2024-02-19

3. Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV;BMC Infectious Diseases;2023-09-04

4. Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients;Journal of Antimicrobial Chemotherapy;2021-05-20

5. Transmitted drug resistance among HIV-1 drug-naïve patients in Greece;International Journal of Infectious Diseases;2021-04